𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intracorporeal pneumatic shock application for the treatment of chronic plantar fasciitis: a randomized, double blind prospective clinical trial

✍ Scribed by Yunus Dogramaci; Aydiner Kalaci; Anıl Emir; Ahmet Nedim Yanat; Ahmet Gökçe

Publisher
Springer
Year
2009
Tongue
English
Weight
294 KB
Volume
130
Category
Article
ISSN
1434-3916

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, placebo-controlled, double-b
Randomized, placebo-controlled, double-blind clinical trial evaluating the treatment of plantar fasciitis with an extracoporeal shockwave therapy (ESWT) device: A North American confirmatory study
✍ Patricia Kudo; Katie Dainty; Michael Clarfield; Larry Coughlin; Pauline Lavoie; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 145 KB

## Abstract Despite numerous publications and clinical trials, the results of treatment of recalcitrant chronic plantar fasciitis with extracorporeal shockwave therapy (ESWT) still remain equivocal as to whether or not this treatment provides relief from the pain associated with this condition. The

A clinical, prospective, randomized, dou
A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in the treatment of melasma
✍ Alessandra Lima Haddad; Luiz Fernando Matos; Flavia Brunstein; Lydia Masako Fer 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

## Abstract **Objectives** To compare, in a double‐blind, randomized, prospective study, the clinical improvement of hyperpigmentation in 30 patients with melasma using hydroquinone or skin whitening complex topically on one side of the face vs. a placebo cream on the other. The study was performed

Combination therapy with thymosin α1 and
Combination therapy with thymosin α1 and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo-controlled double-blind trial
✍ Kenneth E. Sherman; Maria Sjogren; Robin L. Creager; Melissa A. Damiano; Stephen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

Hepatitis C is a major cause of liver disease leading to cirrhosis. Although interferon (IFN) is the only approved therapy, treatment is characterized by low response rates and dose-limiting side effects. We evaluated the addition of thymosin ␣1 (TA1), an immunomodulatory peptide, to the standard tr

A multicenter, prospective, randomized,
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
✍ Rachel K. Hoyles; Ross W. Ellis; Jessica Wellsbury; Belinda Lees; Pauline Newlan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

## Abstract ## Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic sclerosis (SSc) has hampered an evidence‐based approach to treatment. This RCT was undertaken to investigate the effects of intravenous (IV) cyclophosphamide (CYC) followed by azathioprine (A